Senti Biosciences Inc   (SNTI)
Other Ticker:  


Senti Biosciences Inc

SNTI's Financial Statements and Analysis

Senti Biosciences Inc increased first quarter of 2023 net loss per share of $-0.42 compare to net loss per share of $-0.11 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.51 realized in previous quarter.

first quarter of 2023
Earnings Per Share Revenues
$ -0.42 $  1 Mill
$-0.31     $+1M    

Senti Biosciences Inc 's Revenue rose by 0 % in first quarter of 2023 (Mar 31 2023) year on year, to $1 million and advanced by 10.67 % sequentially.

Senti Biosciences Inc is Expected to report next financial results on August 11, 2023.

More on SNTI's Income Statement

Senti Biosciences Inc 's in thefirst quarter of 2023 recorded net loss of $-18.722 million, an increase from net loss of $-3.358 million in IV. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-29.726 million realized in previous quarter.

More on SNTI's Growth

Senti Biosciences Inc Inventories
In Mar 31 2023 company's net cash and cash equivalents decreased by $-26 million, capital expenditures fell by